Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Creative Medical Technology Holdings (CELZ) EPS (Basic) (2016 - 2025)

Creative Medical Technology Holdings (CELZ) has disclosed EPS (Basic) for 15 consecutive years, with -$0.75 as the latest value for Q3 2024.

  • On a quarterly basis, EPS (Basic) rose 26.45% to -$0.75 in Q3 2024 year-over-year; TTM through Sep 2024 was -$0.75, a 26.45% increase, with the full-year FY2023 number at -$3.76, down 303.83% from a year prior.
  • EPS (Basic) was -$0.75 for Q3 2024 at Creative Medical Technology Holdings, up from -$1.11 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $12.22 in Q1 2021 to a low of -$63.35 in Q4 2020.
  • A 5-year average of -$3.28 and a median of -$0.75 in 2024 define the central range for EPS (Basic).
  • Peak YoY movement for EPS (Basic): skyrocketed 36544.5% in 2020, then tumbled 12653.42% in 2021.
  • Creative Medical Technology Holdings' EPS (Basic) stood at -$63.35 in 2020, then soared by 95.88% to -$2.61 in 2021, then skyrocketed by 81.61% to -$0.48 in 2022, then tumbled by 148.43% to -$1.19 in 2023, then surged by 37.35% to -$0.75 in 2024.
  • Per Business Quant, the three most recent readings for CELZ's EPS (Basic) are -$0.75 (Q3 2024), -$1.11 (Q2 2024), and -$0.73 (Q1 2024).